Tomas Olsson Selected Research

Tomas Olsson Research Topics

Disease

142	Multiple Sclerosis 02/2024 - 03/2002
30	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 07/2002
21	Inflammation (Inflammations) 01/2022 - 03/2003
20	Autoimmune Diseases (Autoimmune Disease) 02/2024 - 09/2003
16	Relapsing-Remitting Multiple Sclerosis 08/2023 - 02/2003
16	Neuroinflammatory Diseases 12/2020 - 12/2002
12	Disease Progression 02/2024 - 09/2003
12	Infections 12/2023 - 09/2009
10	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 07/2002
9	Epstein-Barr Virus Infections 12/2021 - 09/2012
8	Progressive Multifocal Leukoencephalopathy 05/2021 - 09/2009
7	Obesity 10/2021 - 03/2014
6	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022 - 05/2005
5	Infectious Mononucleosis (Glandular Fever) 01/2021 - 09/2014
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 01/2015
5	Postpoliomyelitis Syndrome (Post-Polio Syndrome) 07/2012 - 12/2002
4	Narcolepsy 01/2023 - 05/2014
4	Genetic Risk Score 11/2020 - 10/2016
4	Rheumatoid Arthritis 01/2020 - 05/2005
4	Encephalomyelitis (Myeloencephalitis) 04/2009 - 07/2003
3	COVID-19 12/2023 - 01/2021
3	Pain (Aches) 08/2023 - 07/2012
3	Congenital heart block 01/2022 - 01/2005
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2016
3	Dementia (Dementias) 01/2021 - 01/2019
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 05/2011
3	Cognitive Dysfunction 01/2021 - 11/2019
3	Pediatric Obesity 01/2021 - 01/2016
3	Neoplasms (Cancer) 01/2020 - 09/2010
3	Human Influenza (Influenza) 10/2017 - 05/2014
3	Central Nervous System Diseases (CNS Diseases) 12/2016 - 10/2013
3	Nervous System Diseases (Neurological Disorders) 05/2014 - 09/2010
3	Poliomyelitis (Polio) 03/2006 - 12/2002
2	Psychotic Disorders (Schizoaffective Disorder) 10/2023 - 11/2020
2	Fatigue 02/2023 - 03/2016
2	Polyneuropathies (Polyneuropathy) 01/2023 - 12/2012
2	Guillain-Barre Syndrome 01/2023 - 12/2012
2	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2023 - 12/2012
2	Atrioventricular Block 01/2022 - 01/2005
2	Measles 01/2022 - 07/2015
2	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 05/2012
2	Vitamin D Deficiency 04/2020 - 12/2010

Drug/Important Bio-Agent (IBA)

24	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2009
22	Myelin-Oligodendrocyte GlycoproteinIBA 01/2019 - 07/2002
21	Proteins (Proteins, Gene)FDA Link 10/2023 - 09/2003
19	AntibodiesIBA 10/2023 - 10/2007
18	Vitamin D FDA LinkGeneric 02/2024 - 09/2010
18	Natalizumab (Tysabri)FDA Link 01/2023 - 09/2009
16	AutoantibodiesIBA 01/2022 - 09/2003
13	HLA-DRB1 Chains (HLA DRB1)IBA 01/2024 - 03/2014
12	Immunoglobulin G (IgG)IBA 01/2022 - 06/2012
11	AntigensIBA 01/2021 - 06/2008
11	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 03/2011
9	CytokinesIBA 01/2019 - 11/2002
8	Oligoclonal BandsIBA 12/2016 - 01/2013
7	Messenger RNA (mRNA)IBA 12/2023 - 12/2002
7	Peptides (Polypeptides)IBA 01/2017 - 02/2003
5	Fingolimod Hydrochloride (FTY720)FDA Link 12/2023 - 12/2014
5	Rituximab (Mabthera)FDA Link 11/2022 - 04/2011
5	AutoantigensIBA 04/2022 - 10/2003
5	EBV-encoded nuclear antigen 1IBA 12/2021 - 01/2020
5	HLA-A Antigens (HLA-A)IBA 11/2020 - 09/2012
5	LigandsIBA 08/2016 - 09/2007
5	EpitopesIBA 10/2015 - 01/2005
4	ORALIT (ORS)IBA 01/2024 - 01/2020
4	VaccinesIBA 12/2023 - 01/2016
4	Blood Proteins (Serum Proteins)IBA 01/2022 - 12/2011
4	Myelin Basic ProteinIBA 01/2021 - 02/2003
4	SolventsIBA 01/2019 - 01/2016
4	Complement System Proteins (Complement)IBA 01/2015 - 10/2007
4	Intravenous Immunoglobulins (IVIG)FDA Link 07/2012 - 05/2004
3	hydroxide ionIBA 02/2024 - 04/2013
3	Glatiramer Acetate (Copaxone)FDA Link 01/2023 - 01/2015
3	InterferonsIBA 01/2023 - 10/2020
3	OrexinsIBA 01/2023 - 05/2014
3	Interferon-betaIBA 01/2022 - 11/2014
3	HLA-DR15 antigenIBA 01/2021 - 01/2018
3	Interleukin-22 (IL-22)IBA 01/2019 - 12/2010
3	LipidsIBA 11/2017 - 06/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 02/2003
3	OsteopontinIBA 08/2016 - 01/2011
3	ChemokinesIBA 08/2016 - 10/2003
3	Interleukin-7 (Interleukin 7)IBA 11/2014 - 09/2007
3	Monoclonal AntibodiesIBA 12/2012 - 04/2011
3	Immunoglobulins (Immunoglobulin)IBA 06/2012 - 12/2006
3	MHC class II transactivator proteinIBA 07/2009 - 05/2005
2	25-hydroxyvitamin DIBA 02/2024 - 09/2014
2	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2023 - 12/2014
2	ponesimodIBA 01/2022 - 11/2014
2	SmokeIBA 01/2022 - 07/2014
2	Prostate-Specific Antigen (Semenogelase)IBA 04/2021 - 05/2012
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2021
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 08/2010
2	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2021 - 01/2021
2	Dimethyl FumarateIBA 10/2020 - 12/2019
2	Retinaldehyde (Retinal)IBA 11/2019 - 01/2017
2	Integrin alpha4beta1 (VLA-4)IBA 01/2019 - 04/2014
2	Coffee FDA Link 01/2019 - 01/2017

Therapy/Procedure

20	Therapeutics 12/2023 - 04/2011
2	Immunotherapy 08/2023 - 12/2015